[Monocytosis is an independent risk marker for coronary artery disease]

Abrahão Afiune Neto1, Antonio de Pádua Mansur, Solange Desirée Avakian

  • 1Instituto do Coração, Hospital das Clínicas, FMUSP, São Paulo, SP. afiune@cardiol.br

Insights

Elevated monocyte counts indicate a higher risk for coronary artery disease (CAD) and acute myocardial infarction (AMI). This finding highlights monocytes as key inflammatory markers in atherosclerosis.

Area of Science:

  • Immunology
  • Cardiovascular Medicine
  • Hematology

Context:

  • Atherosclerosis pathogenesis involves inflammation and immune cell activation.
  • White blood cell differentials are crucial in assessing cardiovascular risk.
  • Chronic coronary artery disease (CAD) and acute myocardial infarction (AMI) represent significant cardiovascular events.

Purpose:

  • To analyze white blood cell counts, specifically neutrophils, eosinophils, lymphocytes, monocytes, and basophils.
  • To compare these counts in patients with chronic CAD and AMI against a control group.
  • To determine the independent predictive value of specific white blood cell types for CAD and AMI.

Summary:

  • A study of 232 patients (142 with CAD, 90 controls) found higher leukocytosis in CAD patients, particularly those with AMI.
  • Monocyte counts were significantly elevated in CAD and AMI groups compared to controls.
  • Multivariate analysis identified monocytosis as an independent risk marker for both CAD and AMI.

Impact:

  • Monocytes are identified as critical inflammatory components within atherosclerotic plaques.
  • This research establishes monocyte count as a valuable independent risk marker for CAD and AMI.
  • Findings may inform diagnostic and prognostic strategies for cardiovascular diseases.
Abstract

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...